ATE411055T1 - Verbesserungen für oder in bezug auf kontrastmittel - Google Patents

Verbesserungen für oder in bezug auf kontrastmittel

Info

Publication number
ATE411055T1
ATE411055T1 AT97934662T AT97934662T ATE411055T1 AT E411055 T1 ATE411055 T1 AT E411055T1 AT 97934662 T AT97934662 T AT 97934662T AT 97934662 T AT97934662 T AT 97934662T AT E411055 T1 ATE411055 T1 AT E411055T1
Authority
AT
Austria
Prior art keywords
contrast agents
relating
phospholipid
perfluorocarbon
microbubbles
Prior art date
Application number
AT97934662T
Other languages
English (en)
Inventor
David Johnson
Jonny Ostensen
Morten Eriksen
Audun Tornes
Sigmund Frigstad
Harald Dugstad
Jo Klaveness
Pal Rongved
Roald Skurtveit
Jorunn Braenden
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9616301.9A external-priority patent/GB9616301D0/en
Priority claimed from GBGB9705918.2A external-priority patent/GB9705918D0/en
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE411055T1 publication Critical patent/ATE411055T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT97934662T 1996-08-02 1997-08-04 Verbesserungen für oder in bezug auf kontrastmittel ATE411055T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616301.9A GB9616301D0 (en) 1996-08-02 1996-08-02 Improvements in or relating to contrast agents
GBGB9705918.2A GB9705918D0 (en) 1997-03-21 1997-03-21 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
ATE411055T1 true ATE411055T1 (de) 2008-10-15

Family

ID=26309806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934662T ATE411055T1 (de) 1996-08-02 1997-08-04 Verbesserungen für oder in bezug auf kontrastmittel

Country Status (16)

Country Link
US (1) US7892522B2 (de)
EP (1) EP0918546B1 (de)
JP (2) JP3634869B2 (de)
KR (1) KR100593873B1 (de)
CN (1) CN1104911C (de)
AT (1) ATE411055T1 (de)
AU (1) AU3780497A (de)
CA (1) CA2262908A1 (de)
CZ (1) CZ28999A3 (de)
DE (1) DE69739047D1 (de)
ES (1) ES2316157T3 (de)
IL (2) IL128345A (de)
MX (1) MXPA99001053A (de)
NO (1) NO990276L (de)
NZ (1) NZ334365A (de)
WO (1) WO1998005364A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708246D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9809084D0 (en) * 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
US6548048B1 (en) 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (de) 2002-03-01 2007-03-21 Dyax Corp Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
ATE480263T1 (de) * 2003-02-04 2010-09-15 Bracco Suisse Sa Ultraschall kontrastmittel und verfahren zur erstellung
DK2949658T3 (en) 2003-03-03 2018-10-01 Dyax Corp Peptides that specifically bind HGF receptor (cMet) and uses thereof
US9750821B2 (en) 2003-12-22 2017-09-05 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
EP1784228B1 (de) 2004-08-18 2016-10-05 Bracco Suisse SA Gasgefüllte mikrovesikelzusammensetzung für kontrastbilddarstellungen
WO2006076826A1 (fr) * 2005-01-18 2006-07-27 Institute Of Pharmacology Toxicology, Academy Of Military Medical Sciences Composition de contraste pour ultrasons utilisant un phospholipide filmogene et procede de preparation de celle-ci
JP2006335745A (ja) * 2005-06-06 2006-12-14 Fujifilm Holdings Corp リポソームを含むｍｒｉ造影剤
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
CN101374955B (zh) 2005-12-09 2013-03-27 布拉科瑞士有限公司 靶向载体-磷脂缀合物
WO2007070827A2 (en) * 2005-12-15 2007-06-21 Bristol-Myers Squibb Pharma Company Contrast agents for myocardium perfusion imaging
AU2008331764A1 (en) 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
AU2009257279A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
JP6594772B2 (ja) 2012-04-30 2019-10-23 ジーイー・ヘルスケア・アクスイェ・セルスカプ 発泡性組成物を容器に充填する方法
WO2014142927A1 (en) * 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
US20170136144A1 (en) 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
CN110381854A (zh) 2017-01-05 2019-10-25 考恩特兰有限公司 用于植入和逆转刺激响应性植入物的方法
EP3880273A4 (de) 2018-11-13 2022-08-24 Contraline, Inc. Systeme und verfahren zur abgabe von biomaterialien
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2129685B (en) * 1982-11-11 1985-11-13 Nat Biolog Standards Board Anti-haemophilic compositions
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
WO1995026205A1 (en) * 1994-03-28 1995-10-05 Nycomed Imaging A/S Liposomes
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
PT881915E (pt) * 1996-02-19 2003-09-30 Amersham Health As Melhorias em ou relativas a agentes de contraste
CA2246778A1 (en) * 1996-02-19 1997-08-21 Per Helge Gulliksen Thermally stabilized contrast agent
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
JP3634869B2 (ja) 2005-03-30
IL128345A0 (en) 2000-01-31
NO990276D0 (no) 1999-01-22
US7892522B2 (en) 2011-02-22
KR100593873B1 (ko) 2006-07-03
US20020106328A1 (en) 2002-08-08
CZ28999A3 (cs) 1999-07-14
IL128345A (en) 2003-06-24
CN1104911C (zh) 2003-04-09
NZ334365A (en) 1999-10-28
EP0918546A2 (de) 1999-06-02
JP2000517296A (ja) 2000-12-26
KR20000029780A (ko) 2000-05-25
CA2262908A1 (en) 1998-02-12
MXPA99001053A (es) 2002-03-11
AU3780497A (en) 1998-02-25
JP2004002453A (ja) 2004-01-08
EP0918546B1 (de) 2008-10-15
ES2316157T3 (es) 2009-04-01
WO1998005364A3 (en) 1998-06-18
NO990276L (no) 1999-01-22
CN1227502A (zh) 1999-09-01
DE69739047D1 (de) 2008-11-27
WO1998005364A2 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
ATE411055T1 (de) Verbesserungen für oder in bezug auf kontrastmittel
NO981944L (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
DE69508598T2 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
HUP9900813A2 (hu) Továbbfejlesztett kontrasztanyagok
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ATE287700T1 (de) Strahlung-sensitive liposomen
PT852490E (pt) Formulacoes em emulsao para a entrega de substancias biologicamente activas a celulas
DK0478686T3 (da) Flour- og phosphorholdige amphiphile molekyler med overfladeaktive egenskaber
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
DE69739277D1 (de) N-acyl-phosphatidylethanolamin-vermittelte wirkstoffdarreichung in liposomenform
DE69616523T2 (de) Verfahren zur baladung von lipidvesikeln
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
DE69828038D1 (de) Lipidkomplexe von sehr unlöslichen platinkomplexen
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
KR910021246A (ko) 인지질 기제의 제약학적 조성물
BR0112337A (pt) Derivados de fosfolipìdeos de ácido valpróico e suas misturas
IT1270618B (it) Proteine ad attivita' antitumorale
AU4152799A (en) Glycoproteins having lipid mobilising properties and therapeutic applications thereof
BR9812875A (pt) Processos para o tratamento de artrite reumatóide em um mamìfero, e para a fabricação de uma composição terapêutica para o tratamento de artrite reumatóide em um mamìfero, uso de um composto, e, composição farmacêutica
ATE396706T1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
DE69520231D1 (de) Liposomzubereitungen enthaltend hybrid-interferon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties